USING TYPE III PEGYLATED INTERFERONS FOR TREATING HEPATITIS C

摘要

FIELD: medicine.;SUBSTANCE: group of inventions refers to medicine, namely to infectious diseases and may be used for treating and preventing hepatitis C in an individual received no drug therapy while being infected or at a risk of infection. That is ensured by subcutaneous introduction of mPEG-propionaldehyde pegylated polypeptide 1.5-5.0 mcg/kg having molecular weight approximately 20 kDa. The polypeptide contains the amino acid residues 1-176 SEQ ID NO: 106. and is pegylated type III interferon.;EFFECT: group of inventions provides treating hepatitis C in the above group of patients and reducing the toxic effects of the drugs administered.;11 cl, 113 dwg, 18 tbl, 1 ex